ATRA vs DASH
Atara Biotherapeutics Inc (ATRA) versus DoorDash, Inc. Class A Common Stock (DASH) — a side-by-side from cached financials, not a winner call.
Atara Biotherapeutics Inc (ATRA) is a biotechnology company listed on NASDAQ.
DoorDash, Inc. Class A Common Stock (DASH) is a internet retail company listed on US.
Latest reported ATRA revenue for 2024-12-31 was $128.9M. Net income was -$85.4M. Revenue was up 1404.0% from 2023-12-31 to 2024-12-31. ATRA currently screens at market cap $87.1M.
Latest reported DASH revenue for 2025-12-31 was $13.72B. Net income was $935.0M. Revenue was up 27.9% from 2024-12-31 to 2025-12-31. DASH currently screens at market cap $69.41B and trailing P/E 75.9.
ATRA currently screens at market cap $87.1M. DASH currently screens at market cap $69.41B and trailing P/E 75.9.
Not investment advice. Open the ATRA and DASH stock pages for the full models.
Not investment advice.